4
Changes in Ownership
Disc Medicine, Inc. Filed Acc 0000950170-23-070394
Chief Financial Officer sold 2,500 shares at $65.22 ($163,062)
- Chief Financial Officer acquired 2,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bryce Joanne · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,500 | $2.65 | $6,625 | 5,000 | D |
| 2023-12-12 | Sale : show line 2 in the form 10b5-1 | −2,500 | $65.22 | $163,062 | 2,500 | D |
| Open-market sales · 2,500 sh · avg $65.22 · $163,062 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-12 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −2,500 | 2,253 | D |
Loading xslF345X05/ownership.xml…